Syros Pharmaceuticals is on the Cruelty Free Investing use of animals list because they use animals for drug testing and clinical trials.
The company stated in the following report that they conduct pre-clinical trials of their drugs on animals.
“After confirming the selective role of CDK7 in TNBC, the authors conducted a series of experiments that demonstrated the strong potential of CDK7 inhibition to reduce tumor cell proliferation and induce cancer cell death in animal models.”(Page 1) Read the full document
Syros Pharmaceuticals, Inc., incorporated on November 9, 2011, is a biopharmaceutical company. The Company offers a gene control platform designed to analyze the unexploited region of deoxyribonucleic acid (DNA) in human disease tissue to identify and drug targets linked to genomically defined patient populations. [Source: Reuters]
Company Website: http://syros.com